GM1 ganglioside reduces cognitive dysfunction after focal cortical ischemia
Open Access
- 31 December 1990
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 37 (4) , 679-684
- https://doi.org/10.1016/0091-3057(90)90546-t
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- GM1 Ganglioside treatment after global ischemia protects changes in membrane fatty acids and properties of Na+, K+‐ATPase and Mg2+‐ATPaseJournal of Neuroscience Research, 1989
- GM1 ganglioside therapy in acute ischemic stroke. Italian Acute Stroke Study--Hemodilution + Drug.Stroke, 1989
- Influence of monosialoganglioside inner ester on neurologic recovery after global cerebral ischemia in monkeys.Stroke, 1989
- Interrelationship of brain edema, motor deficits, and memory impairment in rats exposed to focal ischemia.Stroke, 1989
- Current Medical and Surgical Therapy for Cerebrovascular DiseaseNew England Journal of Medicine, 1987
- Gangliosides (GM1 and AGF2) reduce mortality due to ischemia: protection of membrane function.Stroke, 1987
- A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction.Stroke, 1986
- Amnesia in Humans and Animals After Ischemic Cerebral InjuryAnnals of the New York Academy of Sciences, 1985
- Behavioral performance of rats following transient forebrain ischemia.Stroke, 1984
- A comparison of the contributions of the frontal and parietal association cortex to spatial localization in rats.Behavioral Neuroscience, 1983